adminThe headlines aren’t being polite about it: 1792 Exchange has just lit a public fuse under corporate America. Using the Human Rights Campaign’s Corporate Equality Index as a roadmap, CEO Douglas Napier says his group identified 568 companies whose CEI answers suggest their employee health plans — and likely dependent coverage — will pay for gender‑transition care. The message to those companies is blunt: stop covering irreversible treatments for minors, publicly carve out under‑18s, and stop taking marching orders from the HRC scorecard.
What 1792 Exchange actually did
This week 1792 Exchange sent letters to dozens of firms it says earned full points under CEI “Inclusive Benefits.” The group points out that the CEI asks companies whether they offer comprehensive coverage for transgender‑related medical care and that most employer plans extend coverage to dependents. From that logic 1792 draws the conclusion — reasonable to many parents — that those companies’ plans likely cover minors for gender‑affirming drugs and surgeries.
Some familiar names appear in the list 1792 publicized: Amazon, Disney, Nike, Starbucks, CVS, Macy’s, Kroger and others. 1792 even holds up Walmart’s Summary Plan Description as a model, because Walmart explicitly says certain surgeries aren’t medically necessary for under‑18s. In short: 1792 gave CEOs a choice — protect kids publicly or keep funding controversial care quietly.
Why this move matters
This isn’t just about corporate virtue signaling or which groups a company pats on the back. It’s about children. Parents and medical skeptics point to stories like Chloe Cole’s and reviews like the Cass Review when they argue pediatric interventions carry lifelong consequences. Whether you call it caution or common sense, many Americans believe employers shouldn’t underwrite treatments that can sterilize or permanently change healthy bodies before a young person has reached full maturity.
And yes, there’s money on the table too. 1792 warns about rising detransition lawsuits and legal exposure for sponsors of these plans. CEOs don’t like being dragged into courtroom battles because HR wanted a higher score on a progressive checklist. That’s a practical argument that ought to hit home in boardrooms faster than any op‑ed.
Legal reality and the CEI caveat
To be clear, the HRC’s Corporate Equality Index scores come from company‑submitted information. A top CEI score doesn’t automatically reveal every nuance of every health plan contract. But 1792’s inference — that companies claiming “inclusive benefits” will often extend those benefits to dependents — is not baseless. Conservative activists are right to press for transparency: if a company says one thing to the HRC and families find out something different in their plan booklets, somebody will answer for it.
What companies should do next
For executives who prefer profits to public headaches, the fix is simple and sensible: publish a clear Summary Plan Description, add a public carve‑out excluding minors from invasive transition procedures, and stop treating the HRC CEI as a moral compass. If Walmart can spell it out plainly, so can any company that cares more about protecting kids than scoring points with activist groups.
CEOs who ignore this will find their brands in the crosshairs of parents, voters, and investors who expect common sense from institutions that sell their groceries, clothes, and coffee. The 1792 campaign is loud and direct by design — consider this a public reminder that corporate neutrality on medical matters affecting children is both possible and popular.
That’s the point: this fight isn’t small, and it isn’t over. Companies can choose to protect kids and their reputations, or they can keep chasing a perfect rating while parents pick up the pieces. The sensible path is obvious. The brave one is moral. The rest will pay for their choices sooner or later.
